Ftse Mib
36.371,67
0,00%
DAX
21.623,08
0,00%
S&P 500
6.039,31
-0,47%
NASDAQ
19.632,32
-0,51%
Bitcoin
105.326,23
1,53%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Charles River Laboratories International Inc (CRL) Charles River Laboratories International Inc (CRL) Notizie

Charles River Laboratories International Inc

CRL
161,64
-2,00 (-1,22%)
30 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202522:30BWCharles River Laboratories Schedules Fourth-Quarter 2024..
21/1/202514:00BWCharles River Expands Apollo™ Ecosystem, Offering Bespoke..
16/1/202514:00BWCharles River and Akron Bio Announce Collaboration to..
14/1/202514:04EDGAR2Form 8-K - Current report
13/1/202514:00BWCharles River Laboratories to Present at J.P. Morgan..
13/12/202422:42EDGAR2Form 8-K - Current report
05/12/202414:00BWCharles River Introduces Global Biotech Incubator Program
02/12/202414:00BWCharles River Laboratories to Present at Evercore ISI..
12/11/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/11/202414:00BWCharles River Laboratories to Present at UBS and Jefferies..
09/11/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202423:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
06/11/202415:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:21EDGAR2Form 8-K - Current report
06/11/202413:00BWCharles River Laboratories Announces Third-Quarter 2024..
17/10/202414:00BWCharles River Launches New Retrogenix® Non-Human Protein..
16/10/202422:30BWCharles River Laboratories Schedules Third-Quarter 2024..
03/10/202414:00BWCharles River Provides Translational Expertise at..
02/10/202414:00BWCharles River and Lundbeck Enter Agreement Utilizing..
17/9/202414:00BWCharles River Laboratories and CEBINA Announce Strategic..
04/9/202415:21PRNUSCharles River and Insightec Announce Strategic Collaboration..
04/9/202414:00BWCharles River and Insightec Announce Strategic Collaboration..
03/9/202422:30BWCharles River Laboratories to Present at Baird and Morgan..
13/8/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202419:34EDGAR2Form 144 - Report of proposed sale of securities
07/8/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:21EDGAR2Form 8-K - Current report
07/8/202413:00BWCharles River Laboratories Announces Second-Quarter 2024..
05/8/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:07EDGAR2Form 144 - Report of proposed sale of securities
30/7/202414:00BWCharles River Collaborates with Patient Advocacy Group,..
24/7/202414:00BWCharles River Laboratories and Autobahn Labs Announce..
16/7/202422:30BWCharles River Laboratories Schedules Second-Quarter 2024..
08/7/202414:00BWCharles River to Perform Plasmid Manufacturing for..
25/6/202414:00BWCharles River Laboratories Announces Strategic Lentiviral..
17/6/202414:00BWCharles River and Captain T Cell Announce Plasmid DNA and..
11/6/202414:00BWCharles River Laboratories, in Collaboration With MatTek..
06/6/202414:00BWCharles River Laboratories Expands Access to CRADL® Contract..
04/6/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202414:00BWCharles River Laboratories Announces Development of..
03/6/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:00BWCharles River Laboratories to Present at William Blair and..
Apertura: 163,00 Min: 159,65 Max: 163,05
Chiusura: 163,64

La tua Cronologia

NYSE
CRL
Charles River Laboratories
BOV
PHGN34M
Koninklijke Philips N.V
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci